Polomar Health Services, Inc.: 10-K filed 2026-05-06
What Polomar Health Services, Inc. reported in its annual report filed 2026-05-06 (fiscal FY 2025): 36 published measures, 70 facts as tagged in accession 0001493152-26-021488.
This filing
- Form
- 10-K (annual report)
- Filed
- 2026-05-06
- Fiscal period
- fiscal FY 2025
- Accession
- 0001493152-26-021488 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Polomar Health Services, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 390,043 | USD | |
| At 2024-12-31 | 9,951,773 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 1,612,372 | USD | |
| At 2024-12-31 | 1,352,642 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | -1,222,329 | USD | |
| At 2024-12-31 | 8,599,131 | USD | |
| At 2023-12-31 | -44,536 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 132,150 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | -10,701,105 | USD | 365 |
| 2024-01-01 to 2024-12-31 | -1,341,333 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | -395,995 | USD | 365 |
| 2024-01-01 to 2024-12-31 | -1,019,787 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-12-31 | 90,893 | USD | 366 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 648,231 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 58,824 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 521,954 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 1,108,063 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-12-31 | -90,893 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | -13,612,268 | USD | |
| At 2024-12-31 | -2,911,163 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 27,763,666 | shares | 365 |
| 2024-01-01 to 2024-12-31 | 27,656,094 | shares | 366 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 27,763,666 | shares | 365 |
| 2024-01-01 to 2024-12-31 | 27,656,094 | shares | 366 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | -0.39 | USD/shares | 365 |
| 2024-01-01 to 2024-12-31 | -0.05 | USD/shares | 366 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | -0.39 | USD/shares | 365 |
| 2024-01-01 to 2024-12-31 | -0.05 | USD/shares | 366 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 43,452 | USD | |
| At 2024-12-31 | 81,405 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 129,645 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | -10,550,264 | USD | 365 |
| 2024-01-01 to 2024-12-31 | -1,299,496 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 322,727 | USD | |
| At 2024-12-31 | 76,813 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 1,612,372 | USD | |
| At 2024-12-31 | 1,337,778 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 11,010,363 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 1,330,399 | USD | 366 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 93,636 | USD | |
| At 2024-12-31 | 68,777 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 460,099 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 30,903 | USD | 366 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 188,132 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 27,921 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 28,019,624 | shares | |
| At 2024-12-31 | 27,657,679 | shares | |
| At 2024-11-01 | 27,657,679 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 12,361,919 | USD | |
| At 2024-12-31 | 11,482,636 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 14,864 | USD | |
| At 2024-12-31 | 49,180 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 41,458 | USD | |
| At 2024-12-31 | 41,458 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 47,441 | USD | |
| At 2024-12-31 | 9,488 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-12-31 | 23,864 | USD | |
| At 2024-12-31 | 9,793,555 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 10,943,795 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 1,284,401 | USD | 366 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 150,841 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 41,837 | USD | 366 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | -150,841 | USD | 365 |
| 2024-01-01 to 2024-12-31 | -41,837 | USD | 366 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 150,841 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 41,837 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 95,096 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 1,845 | USD | 366 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 24,859 | USD | 365 |
| 2024-01-01 to 2024-12-31 | 65,316 | USD | 366 |
Inspect the source
- Entity
- Polomar Health Services, Inc. / CIK 0001265521
- Captured
- 2026-09-20T07:47:26.457Z
- SEC response SHA-256
b2bb864aee3291884dec8c553b186abaae72d959c3f62abb5e78d805ebc59d7b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001265521.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))